RESPONSIBILITIES:
Perform general administrative and clerical activities of the office. including office supplies purchase and equipment maintenance.
Responsible for reporting various expenses for the company
Handling incoming and outgoing letters.
Participate in the planning and execution of activities.
Outdoor work is required when necessary.
Assist in ad-hoc duties as and when required.
REQUIREMENTS:
Diploma or above with a minimum of 1 year of relevant experience in office administration.
Fresh graduates will be considered also.
Willing to learn and take up responsibility, detail-oriented and flexible, result-driven.
Good team player, well-organized, and able to work independently.
Proficient command of written and spoken English & Chinese (Cantonese & Mandarin).
Proficient in MS Office including Word, Excel, PowerPoint, and Chinese Word Processing.
Salary |
|
Benefits |
|
Job Function | |
Location |
|
Work Model |
|
Industry | |
Employment Term |
|
Experience |
|
Career Level |
|
Education |
|
滬港中科國際生物科技有限公司(ZSHK Laboratories Limited)總部位於中國香港特別行政區。滬港中科公司以香港特別行政區的國際化人才和扎實的科技發展優勢,在香港科技園、廣東省深圳市坪山區、江蘇省蘇州工業園區都建有獨立實驗設施。公司以生物醫藥和醫療器械的臨床前研究評價服務為主,業務內容包括藥理藥效研究、藥物代謝動力學研究和安全性評價研究的一站式研發服務平臺,以滿足國際申報要求為目標,立志成為中國生物醫藥與醫療器械研發企業,在全球發展和拓展中成為最有價值的研發合作夥伴。滬港中科公司目前在蘇州工業園營運3000平方米的藥物臨床前評價服務實驗設施(安領生物醫藥(蘇州)有限公司)和深圳坪山區9400平方米的新藥與醫療器械評價實驗設施(安領生物醫藥(深圳)有限公司),並與香港科技園建設2000平方米的藥物評價實驗設施。這些實驗室都將具備中國藥品監督管理總局(NMPA)和歐盟OECD的GLP資格認證資格。未來三年,滬港中科公司將成為具有總面積達35000平方米的實驗設施、藥物與醫療器械臨床前評價、國內外註冊申報服務、新藥臨床研究服務、全球專利授權法律服務等全方位一體化研發服務的國際企業。
Headquartered in Hong Kong, ZSHK Laboratory Limited is established by the core team of the Safety Evaluation Center of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The company focuses on preclinical research and evaluation services for biopharmaceutical and medical devices. We provide a one-stop R&D platform for pharmacological efficacy research, pharmacokinetics research and safety evaluation research to meet the rigid requirement from global pharmaceutical regulatory bodies. Determined to become a Chinese biopharmaceutical and medical device R&D enterprise, and become the most valuable R&D partner in global development and expansion, the company operates a 3,000 sq.m preclinical drug evaluation service facility in Suzhou Industrial Park (Anling Biomedical (Suzhou) Co., Ltd.) and a 9,400 sq.m new drug and medical device evaluation laboratory in Pingshan District, Shenzhen (Anling Biomedical (Shenzhen) Co., Ltd.), and is collaborating with Hong Kong Science and Technology Park Corporation to establish a 2,000 sq.m drug evaluation facility All these facilities will be certified with the GLP qualifications from National Medical Products Administration (NMPA) and the European Union OECD. ZSHK strives to provide a comprehensive integration of more than 35,000 sq.m facilities for pre-clinical evaluation of drugs, biopharmaceutical products and medical devices for domestic and foreign registration and declaration services, clinical research services for new drugs, and legal services for global patent authorization.